Value-Based Care Strategies Improve Patient Outcomes

The COVID-19 pandemic has brought changes to health care that will impact us for years to come. While many of its effects were (and are) catastrophic, some changes have been positive - particularly in the improved management of chronic diseases, which provides great momentum for stimulating the growth and success of value-based care (VBC).

Economic logic favors fee-for-value (FFV) vs. fee-for-service (FFS) models. Yet, VBC growth has been hampered by operational difficulties that made few FFV agreements profitable for provider organizations. If there is an upside to the pandemic, it’s the accelerated adoption of an environment in which value-based chronic disease agreements - the logical focus of FFV -can be managed effectively. Providers that continue to embrace innovation in patient care are likely to tap aggressively into this revenue stream.